1.
Papp KA, Merola JF, Gottlieb AB, al. E. Dual neutralization of IL-17A and IL-17F with bimekizumab improves quality of life in patients withmoderate-to-severe plaque psoriasis: results from a Phase 2b study and correlation with clinical response. J of Skin [Internet]. 2018Dec.17 [cited 2020Nov.26];20:S92. Available from: https://jofskin.org/index.php/skin/article/view/489